Tag #Enfortumab Vedotin

Showing 1 to 1 of 1 results

theguardian.com
🌐 85% Global Worthiness
News related image

NHS Approves Cancer Treatment Doubling Survival Rates

The NHS in England has approved enfortumab vedotin with pembrolizumab for over 1,000 bladder cancer patients, a treatment shown to double survival rates compared to chemotherapy in clinical trials, offering extended life expectancy and improved quality of life for those with metastatic disease.

Progress

44% Bias Score

Good Health and Well-being

Showing 1 to 1 of 1 results